M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
